
Drug researcher receives $1.2 million to find compounds to treat fatty liver disease
A Virginia Tech associate professor and University of Virginia professor have received funding to fight a type of nonalcoholic fatty liver disease.

A Virginia Tech associate professor and University of Virginia professor have received funding to fight a type of nonalcoholic fatty liver disease.

The Centers for Disease Control and Prevention recently released a report showing that diseases from vectors, such as mosquitoes, ticks, and fleas, have tripled since 2004 in the U.S.

The bracelet looks unassuming, just like any other smart technology worn around the wrist. But rather than counting steps or heartbeats, it serves another purpose.

Receiving the highest honor from a respected academic association is a once-in-a-lifetime experience, but having that honor bestowed on you by a long-term mentee is almost surreal.

Sigora Solar, Virginia’s largest homegrown solar panel provider, is bringing its unique business model and new jobs to the Research Triangle in North Carolina.

The American Heart Association awarded Patrick Calhoun, a biological sciences graduate student, a predoctoral fellowship to carry out his dissertation research at the Virginia Tech Carilion Research Institute.

U.S. Sen. Mark Warner (D-VA) introduced an amendment that would provide $6 million towards unmanned aircraft systems research to safely integrate them into the national airspace.

Although Virginia Tech and the Hebrew University of Jerusalem are separated by more than 6,000 miles, the two institutions have a lot in common.

The risk of developing autism-spectrum disorders is determined by the mother’s microbiome – the collection of microorganisms that naturally live inside us – during pregnancy, new research from the University of Virginia School of Medicine suggests.

A two-year project will create materials to teach librarians and archivists across the world how to collect, extract, and analyze archived information from the world wide web.
Independent media doesn’t belong to billionaires or big companies – it belongs to you. If you find value in our work, please consider a contribution.